Siga Technologies (SIGA) Gains from Investment Securities (2013 - 2025)
Siga Technologies (SIGA) reported Gains from Investment Securities of $67045.0 for Q3 2025, up 181.63% on a YoY basis from $23806.3 in Q3 2024, and up 117.32% quarter-over-quarter from $30851.0 in Q2 2025.
Siga Technologies (SIGA) Gains from Investment Securities (2013 - 2025) Analysis & Trends
Siga Technologies has reported Gains from Investment Securities for 13 years, with the latest figure at $67045.0 in Q3 2025.
- For the quarter ending Q3 2025, Gains from Investment Securities rose 181.63% year-over-year to $67045.0; the trailing twelve-month figure through Sep 2025 stood at $67045.0 (up 181.63% YoY), and the FY2024 full-year result was $629257.0, up 201.68% from the prior year.
- Gains from Investment Securities for Q3 2025 stood at $67045.0, up from $30851.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $214794.0 in Q2 2023, with the low at -$738751.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$18822.7 across 5 years, with a median of $1973.0 in 2022.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities sank 92.72% — and 2023, when it soared 10786.67%.
- Siga Technologies' Gains from Investment Securities stood at $27105.0 in 2021, then plunged by 181.27% to -$22028.0 in 2022, then soared by 1075.1% to $214794.0 in 2023, then tumbled by 443.93% to -$738751.0 in 2024, then surged by 109.08% to $67045.0 in 2025.
- The last three Gains from Investment Securities figures came in at $67045.0 (Q3 2025), $30851.0 (Q2 2025), and $26408.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Siga Technologies | 312.94 Mn | 157.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 67,045.00 |
| Sep 30, 2025 | 67,045.00 |
| Jun 30, 2025 | 30,851.00 |
| Jun 30, 2025 | 30,851.00 |
| Mar 31, 2025 | 26,408.00 |
| Mar 31, 2025 | 26,408.00 |
| Dec 31, 2024 | -738,751.00 |
| Dec 31, 2024 | -738,751.00 |
| Sep 30, 2024 | -82,136.00 |
| Sep 30, 2024 | -82,136.00 |
| Jun 30, 2024 | 25,669.00 |
| Jun 30, 2024 | 25,669.00 |
| Mar 31, 2024 | 158,980.00 |
| Mar 31, 2024 | 158,980.00 |
| Jun 30, 2023 | 214,794.00 |
| Jun 30, 2023 | 214,794.00 |
| Dec 31, 2022 | -22,028.00 |
| Dec 31, 2022 | -22,028.00 |
| Sep 30, 2022 | 1,973.00 |
| Sep 30, 2022 | 1,973.00 |